Login / Signup

SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel.

Annapaola SantoroAndrea CapriDaniele PetroneFrancesca ColavitaSilvia MeschiGiulia MatusaliKlizia MizzoniStefania NotariChiara AgratiDelia GolettiPatrizio PezzottiVincenzo Puro
Published in: Biomedicines (2023)
Routine testing for vaccine-induced humoral immune response to SARS-CoV-2 is not recommended if measured as parameters of 'protective immunity' from SARS-CoV-2 after vaccination. Whether these findings apply to new Omicron-specific bivalent vaccines is going to be evaluated.
Keyphrases
  • sars cov
  • immune response
  • respiratory syndrome coronavirus
  • high glucose
  • coronavirus disease
  • drug induced
  • diabetic rats
  • emergency department
  • clinical practice
  • adverse drug
  • binding protein